Transgenic Animal Market, By Animal Type (Mice, Rats, Zebrafish, Pigs, Cattle, Sheep, Goats, Chickens, and Others (Non-human primates rabbits)), By Technology (Microinjection, Embryonic Stem Cell (ESC) Injection, Nuclear Transfer (Cloning), CRISPR/Cas9 and Other Gene Editing Technologies, and Viral Vector-mediated Transgenesis), By Application (Biomedical Research, Drug Discovery and Development, Toxicology and Safety Testing, Disease Modeling, Regenerative Medicine, Xenotransplantation, Biopharmaceutical Production, and Agricultural Trait Enhancement), By Disease Area (Oncology, Neurological Disorders, Cardiovascular Diseases, Metabolic Disorders, Immunological and Autoimmune Diseases, Genetic and Rare Diseases, and Infectious Diseases), By End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Agricultural Research Organizations, and Government and Regulatory Laboratories), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)